These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38351672)

  • 21. Staging Heart Failure Patients With Secondary Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.
    Stolz L; Doldi PM; Orban M; Karam N; Puscas T; Wild MG; Popescu A; von Bardeleben RS; Iliadis C; Baldus S; Adamo M; Thiele H; Besler C; Unterhuber M; Ruf T; Pfister R; Higuchi S; Koell B; Giannini C; Petronio A; Kassar M; Weckbach LT; Butter C; Stocker TJ; Neuss M; Melica B; Braun D; Windecker S; Massberg S; Praz F; Näbauer M; Kalbacher D; Lurz P; Metra M; Bax JJ; Hausleiter J;
    JACC Cardiovasc Interv; 2023 Jan; 16(2):140-151. PubMed ID: 36697148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials.
    Anker SD; Friede T; von Bardeleben RS; Butler J; Khan MS; Diek M; Heinrich J; Geyer M; Placzek M; Ferrari R; Abraham WT; Alfieri O; Auricchio A; Bayes-Genis A; Cleland JGF; Filippatos G; Gustafsson F; Haverkamp W; Kelm M; Kuck KH; Landmesser U; Maggioni AP; Metra M; Ninios V; Petrie MC; Rassaf T; Ruschitzka F; Schäfer U; Schulze PC; Spargias K; Vahanian A; Zamorano JL; Zeiher A; Karakas M; Koehler F; Lainscak M; Öner A; Mezilis N; Theofilogiannakos EK; Ninios I; Chrissoheris M; Kourkoveli P; Papadopoulos K; Smolka G; Wojakowski W; Reczuch K; Pinto FJ; Zmudka K; Kalarus Z; Adamo M; Santiago-Vacas E; Ruf TF; Gross M; Tongers J; Hasenfuß G; Schillinger W; Ponikowski P
    Eur J Heart Fail; 2024 Jul; 26(7):1608-1615. PubMed ID: 38847420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial.
    Kosmidou I; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Kipperman RM; Boudoulas KD; Redfors B; Shahim B; Zhang Z; Mack MJ; Stone GW
    Circ Heart Fail; 2020 Nov; 13(11):e007293. PubMed ID: 33176460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years.
    Iung B; Armoiry X; Vahanian A; Boutitie F; Mewton N; Trochu JN; Lefèvre T; Messika-Zeitoun D; Guerin P; Cormier B; Brochet E; Thibault H; Himbert D; Thivolet S; Leurent G; Bonnet G; Donal E; Piriou N; Piot C; Habib G; Rouleau F; Carrié D; Nejjari M; Ohlmann P; Saint Etienne C; Leroux L; Gilard M; Samson G; Rioufol G; Maucort-Boulch D; Obadia JF;
    Eur J Heart Fail; 2019 Dec; 21(12):1619-1627. PubMed ID: 31476260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence, Predictors, and Outcomes Associated With Worsening Renal Function in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.
    Kong J; Zaroff JG; Ambrosy AP; Fitzpatrick JK; Ku IA; Mishell JM; Kotinkaduwa LN; Redfors B; Beohar N; Ailawadi G; Lindenfeld J; Abraham WT; Mack MJ; Kar S; Lim DS; Whisenant BK; Stone GW
    J Am Heart Assoc; 2023 Jul; 12(14):e029504. PubMed ID: 37421291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradox of disproportionate atrial functional mitral regurgitation and survival after transcatheter edge-to-edge repair.
    Doldi PM; Stolz L; Kassar M; Kalbacher D; Petronio AS; Butter C; von Bardeleben RS; Iliadis C; Grayburn P; Hausleiter J
    ESC Heart Fail; 2024 Aug; 11(4):2447-2450. PubMed ID: 38602287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.
    Scotti A; Coisne A; Granada JF; Driggin E; Madhavan MV; Zhou Z; Redfors B; Kar S; Lim DS; Cohen DJ; Lindenfeld J; Abraham WT; Mack MJ; Asch FM; Stone GW
    J Am Coll Cardiol; 2023 Jul; 82(2):128-138. PubMed ID: 37306651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
    Mack MJ; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Grayburn PA; Rinaldi MJ; Kapadia SR; Rajagopal V; Sarembock IJ; Brieke A; Rogers JH; Marx SO; Cohen DJ; Weissman NJ; Stone GW;
    J Am Coll Cardiol; 2021 Mar; 77(8):1029-1040. PubMed ID: 33632476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guideline directed medical therapy and reduction of secondary mitral regurgitation.
    Spinka G; Bartko PE; Heitzinger G; Prausmüller S; Winter MP; Arfsten H; Strunk G; Rosenhek R; Kastl S; Hengstenberg C; Pavo N; Hülsmann M; Goliasch G
    Eur Heart J Cardiovasc Imaging; 2022 Jun; 23(6):755-764. PubMed ID: 35466372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial.
    Shahim B; Cohen DJ; Ben-Yehuda O; Redfors B; Kar S; Lim DS; Arnold SV; Li Y; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Heart Assoc; 2023 Feb; 12(4):e028444. PubMed ID: 36752227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
    Mack MJ; Abraham WT; Lindenfeld J; Bolling SF; Feldman TE; Grayburn PA; Kapadia SR; McCarthy PM; Lim DS; Udelson JE; Zile MR; Gammie JS; Gillinov AM; Glower DD; Heimansohn DA; Suri RM; Ellis JT; Shu Y; Kar S; Weissman NJ; Stone GW
    Am Heart J; 2018 Nov; 205():1-11. PubMed ID: 30134187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes following transcatheter repair in patients with functional mitral regurgitation not receiving guideline directed medical therapy in Israel.
    Leibowitz D; Haberman D; Goland S; George J; Beeri R; Planer D; Wolf R; Kutsher B; Hasin T; Shuvy M
    BMC Cardiovasc Disord; 2023 Jun; 23(1):304. PubMed ID: 37328829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex-Specific Outcomes of Transcatheter Mitral-Valve Repair and Medical Therapy for Mitral Regurgitation in Heart Failure.
    Kosmidou I; Lindenfeld J; Abraham WT; Rinaldi MJ; Kapadia SR; Rajagopal V; Sarembock IJ; Brieke A; Gaba P; Rogers JH; Shahim B; Redfors B; Zhang Z; Mack MJ; Stone GW
    JACC Heart Fail; 2021 Sep; 9(9):674-683. PubMed ID: 34391744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrovascular Events After Transcatheter Edge-to-Edge Repair and Guideline-Directed Medical Therapy in the COAPT Trial.
    Vincent F; Redfors B; Kotinkaduwa LN; Kar S; Lim DS; Mishell JM; Whisenant BK; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2023 Jun; 16(12):1448-1459. PubMed ID: 37380226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-hospital complications after MitraClip in patients with heart failure and preserved versus reduced ejection fraction in the United States.
    Krittanawong C; Hahn J; Virk HUH; Bandyopadhyay D; Patel N; Rastogi U; Wang Z; Alam M; Jneid H; Sharma S; Stone GW
    Cardiovasc Revasc Med; 2024 May; 62():34-39. PubMed ID: 38087737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-Related Outcomes After Transcatheter Mitral Valve Repair in Patients With Heart Failure: Analysis From COAPT.
    Song C; Madhavan MV; Lindenfeld J; Abraham WT; Kar S; Lim DS; Grayburn PA; Kapadia SR; Kotinkaduwa LN; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2022 Feb; 15(4):397-407. PubMed ID: 35093278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of rehospitalization after percutaneous edge-to-edge mitral valve repair by MitraClip implantation.
    Keßler M; Seeger J; Muche R; Wöhrle J; Rottbauer W; Markovic S
    Eur J Heart Fail; 2019 Feb; 21(2):182-192. PubMed ID: 30178493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score.
    Hausleiter J; Lachmann M; Stolz L; Bedogni F; Rubbio AP; Estévez-Loureiro R; Raposeiras-Roubin S; Boekstegers P; Karam N; Rudolph V;
    Eur Heart J; 2024 Mar; 45(11):922-936. PubMed ID: 38243773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous repair of mitral valve regurgitation in patients with severe heart failure: comparison with optimal medical treatment.
    Geis N; Raake P; Lewening M; Mereles D; Chorianopoulos E; Frankenstein L; Katus HA; Bekeredjian R; Pleger ST
    Acta Cardiol; 2018 Aug; 73(4):378-386. PubMed ID: 29161956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.